Trial Profile
Effect of dipeptidyl peptidase 4 inhibitors on Glomerulotubular regulation of sodium balance and circadian blood pressure rhythm.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2016
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Teneligliptin (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 19 Oct 2016 New trial record